NANoREG D3.01 DR Gap analysis report, identifying the critical exposure scenarios within the key value chains Acesse: https://www.rivm.nl/en/documenten/nanoreg-d301-dr-gap-analysis-report-identifying-critical-exposure-scenarios-within-key
NANoREG D3.01 DR Gap analysis report, identifying the critical exposure scenarios within the key value chains
ANoREG D2.09 SOP 02 Protocol for effective density measurements
https://www.rivm.nl/en/documenten/nanoreg-d209-sop-02-protocol-for-effective-density-measurements
ANoREG D1 11 DR Definitive framework
https://www.rivm.nl/en/documenten/nanoreg-d1-11-dr-definitive-framework
http://dx.doi.org/10.2760/245972
NANoREG D1 05 DR Workshop on Preliminary feedback from stakeholders on interim output from the project
NANoREG D6 03 DR Comparison on toxicity testing in drug development and in present MNMs safety testing
https://www.rivm.nl/en/documenten/nanoreg-d6-03-dr-comparison-on-toxicity-testing-in-drug-development-and-in-present-mnms
NANoREG D6 06 DR A first attempt to link physicochemical properties to functionalities as a contribution to a Decision tree strategy for the Safe by Design of MNMs
